Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison between American and European legislation in the therapeutical and alimentary bacteriophage usage.

9 Nov 2020

Abstract excerpt

Bacteriophages, though discovered a century ago, still lag behind in the race of antimicrobials due to scarce information about their biology, pharmacology, safety and suitability as therapeutic agents. Although they possess several capabilities of practical utility in medicine, they are still unable to satisfy the regulatory standards set by the regulatory authorities in both United States (US) and European...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Monoclonal and Polyclonal Antibodies Research
Share to Protein purification and stability

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33170166
DOI: 10.23750/abm.v91i13-s.10815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison between American and European legislation in the therapeutical and alimentary bacteriophage usage.PMID 33170166Read ↗

Exploring Bacteriophage Applications in Medicine and BeyondSemantic proximity Read ↗

From forgotten cure to modern medicine: The resurgence of bacteriophage therapySemantic proximity Read ↗

The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant BacteriaSemantic proximity Read ↗

Antibacterial Bioagents Based on Principles of Bacteriophage Biology: An OverviewSemantic proximity Read ↗

Bacteriophage as an Antibacterial Agent: A Patent PerspectiveSemantic proximity Read ↗

The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical LegislationSemantic proximity Read ↗

Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?Semantic proximity Read ↗

Treating bacterial infections with bacteriophages in the 21st centurySemantic proximity Read ↗

The role of regulated clinical trials in the development of bacteriophage therapeuticsSemantic proximity Read ↗

What are the limitations on the wider therapeutic use of phage?Semantic proximity Read ↗

A review on re-emerging bacteriophage therapy in the era of XDRSemantic proximity Read ↗

Phage approved in food, why not as a therapeutic?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.